Pulmonary Disease Clinical Trials in Shanghai, Shanghai Municipality
8 recruitingShanghai, Shanghai Municipality, China
Showing 1–8 of 8 trials
Recruiting
Phase 2
Phase II Study of RC1416 Injection in COPD
Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Nanjing RegeneCore Biotech Co., Ltd.180 enrolled41 locationsNCT07402551
Recruiting
Phase 3
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease
Hoffmann-La Roche2,000 enrolled483 locationsNCT05878769
Recruiting
Phase 2
A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder
Pulmonary Disease, Chronic Obstructive
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.195 enrolled29 locationsNCT07252908
Recruiting
Phase 4
Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease
Mycobacterium Avium Complex Pulmonary Disease
Bin Cao188 enrolled6 locationsNCT07213765
Recruiting
Phase 4
Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease
Mycobacterium Avium Complex Pulmonary Disease
Bin Cao300 enrolled6 locationsNCT07174076
Recruiting
Chronic Airway Disease and Multimorbidity Cohort
AsthmaChronic Obstructive Pulmonary Disease (COPD)Bronchiectasis
China-Japan Friendship Hospital2,000 enrolled9 locationsNCT06798077
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD
Chronic Obstructive Pulmonary Disease (COPD)
Haisco Pharmaceutical Group Co., Ltd.474 enrolled2 locationsNCT06643078
Recruiting
Not Applicable
Effect of Different Oxygen Concentration on Postoperative Pulmonary Complications After Pulmonary Reexpansion
Pulmonary Disease
RenJi Hospital300 enrolled1 locationNCT06202586